Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05240534 · ClinicalTrials.gov registry record · NA
ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI)
A NA study of Chronic Conditions, Multiple, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 502
- Enrollment target
- 1
- Study location
NCT05240534: Active NA study of Chronic Conditions, Multiple, sponsored by University of Wisconsin, Madison.
NCT05240534 is a NA study of Chronic Conditions, Multiple that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 502 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05240534, a NA study of Chronic Conditions, Multiple, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 502 participants
- Enrollment target
- 1
- Study location
Study Summary
Multiple chronic conditions (MCCs) are costly and pervasive among older adults. MCCs account for 90% of Medicare spending, and 65% of Medicare beneficiaries have 3 or more chronic conditions; 23% have 5 or more. MCCs are often addressed in primary care, where time pressures force a focus on medication and lab results rather than self-management skills. Patients often struggle with treatment adherence and the emotional and physical burdens of self-management and health tracking. Chronic conditions reduce quality of life (QOL) and increase loneliness, which exacerbate those conditions. The primary purpose of this study is to investigate whether a voice-based platform is better for delivering an electronic health intervention to older adults than a text/typing-based platform. We have an evidence-based electronic health intervention (Elder Tree, ET) that has been shown to improve quality of life, physical and socio-emotional health outcomes for older adults with multiple chronic conditions when delivered via a text/typing-based system. The current project would test whether such patients would benefit even more if ET were delivered via a voice-based system (vs. the text-based system) because they would use it more consistently. ET is an existing intervention providing tools, motivation, and support on a computer platform to help older adults manage their health.
Primary Outcome
Participant reported measure of overall health and level of physical disability. There are 4 questions with a possible score of 4-16. Lower scores indicate worse outcomes.
Conditions Studied
Interventions
- BEHAVIORAL ET-Text (Laptop)
- BEHAVIORAL ET-Voice (Smart System)
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 502 participants |
| Start Date | 2022-04-29 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
What the registry record for NCT05240534 still lists
NCT05240534 is an interventional study that assigns participants to a tested intervention. The registered 502 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Chronic Conditions, Multiple appearing as the primary indexed condition, and to 2 interventions - of which ET-Text (Laptop) is the first listed.
NCT05240534 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05240534 about?
NCT05240534 is a clinical study titled "ElderTree Via a Voice Activated Device for Managing Chronic Health Conditions (NHLBI)". Multiple chronic conditions (MCCs) are costly and pervasive among older adults. MCCs account for 90% of Medicare spending, and 65% of Medicare beneficiaries have 3 or more chronic conditions; 23% have 5 or more. MCCs are often addressed in primary care, where time pressures force a focus on medicati...
What is the current status of trial NCT05240534?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 502 participants. The study started on 2022-04-29. Estimated completion is 2027-04-30.
What conditions does trial NCT05240534 study?
This clinical trial studies the following conditions: Chronic Conditions, Multiple.
What interventions are being tested in trial NCT05240534?
The interventions under investigation include: ET-Text (Laptop) (BEHAVIORAL), ET-Voice (Smart System) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05240534?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05240534 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Conditions, Multiple
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05240534's enrollment target sits among peer trials
502 193rd of 2000 higher than 1,808 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05646381 · 502 participants · Phase 2
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve Stenosis
- NCT05897632 · 502 participants · NA
CARE-CP (Testing a Cardiovascular Ambulatory Rapid Evaluation for Patients With Chest Pain)
- NCT05143931 · 503 participants · NA
Avoid and Resist Strategies for Weight Management
- NCT04442022 · 501 participants · Phase 2
A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI